Re: A randomised, double-blind phase III study of pazopanib in patients with advanced and/or metastatic renal cell carcinoma: final overall survival results and safety update
| Autor: | Ashish M. Kamat, H. B. Grossman, R. E. Millikan, Dallas Williams, Colin P.N. Dinney, Arlene O. Siefker-Radtke, Yu Shen |
|---|---|
| Přispěvatelé: | Cancer Center Amsterdam, Amsterdam Public Health, Urology |
| Rok vydání: | 2013 |
| Předmět: |
Oncology
Male medicine.medical_specialty Chemotherapy Sulfonamides Ifosfamide business.industry Urology medicine.medical_treatment Locally advanced Phases of clinical research Gemcitabine Kidney Neoplasms Pyrimidines Internal medicine medicine Urothelial cancer Humans Doxorubicin Female Cisplatin/gemcitabine business Carcinoma Renal Cell medicine.drug |
| Zdroj: | Journal of urology, 190(6). Elsevier Inc. |
| ISSN: | 1527-3792 0022-5347 |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|